Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
CD200R1L	"CD200R2, CD200RLa"	ENSG00000206531	"CD200 receptor 1 like"	Q6Q8B3	3	112815709-112846856	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	85	"blood: 31.3;testis: 7.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.9;CACO-2: 3.5;CAPAN-2: 1.3;RPMI-8226: 1.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	304	"basophil: 31.3"	"Lineage enriched"	"Detected in single"	313	"granulocytes: 31.3"																					"unprognostic (3.80e-1)"				"unprognostic (1.88e-1)"		"unprognostic (2.37e-2)"		"unprognostic (1.55e-1)"				"unprognostic (1.16e-2)"	"unprognostic (1.78e-1)"		"unprognostic (1.40e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.8			0.0		0.0	0.0	0.0	0.0	0.0	31.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	31.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM64	"C11orf28, TRIM64A"	ENSG00000204450	"Tripartite motif containing 64"	A6NGJ6	11	89968502-89975228	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	65	"blood: 8.6;placenta: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	86	"basophil: 8.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.6"									HPA045370	Approved									"HPA045370: AB_2679298"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		4.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM64B		ENSG00000189253	"Tripartite motif containing 64B"	A6NI03	11	89869282-89876017	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	24	"blood: 22.3;placenta: 7.0"	"Cell line enhanced"	"Detected in single"		"WM-115: 1.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	223	"basophil: 22.3"	"Lineage enriched"	"Detected in single"	223	"granulocytes: 22.3"									HPA045370	Approved									"HPA045370: AB_2679298"															"unprognostic (2.08e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	7.0		0.0	0.0		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.6			0.2		0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.4	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"blood: 494.6"	"Cell line enriched"	"Detected in some"	94	"HEL: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"basophil: 494.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 494.6"					"Low region specificity"	"Detected in all"			"CAB022102, HPA036051, CAB055526"	Approved									"CAB022102: , CAB055526: , HPA036051: "	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	5.8	1.4	1.6	3.6	0.8	6.0	9.2	0.9	1.3	8.0	3.4	1.1	3.4	3.2	10.6	5.6	12.1	2.0	25.4	4.1	4.3	1.3	3.6	2.4	27.8	0.6	1.0	5.3	1.5	2.6	0.5	1.9	0.5	2.7	9.4	5.4	6.5	5.9	4.7	1.2	17.9	4.1	6.0	2.8	3.5	2.3	1.5	6.8	2.4	2.5	19.7	16.2	3.8	4.9	0.0	75.4	494.6	0.3	0.4	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	97.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	494.6	0.3	0.9	0.0	0.1	0.1	0.0	0.1	0.0	75.4	0.0	0.0	0.1	0.4	0.4	0.2	10.4	0.0	3.0	1.6	0.8	0.9	1.3	4.3	1.3	1.0	5.3	2.7	6.8
TRIM49D1	"TRIM49D, TRIM49D1P, TRIM49DP"	ENSG00000223417	"Tripartite motif containing 49D1"	C9J1S8	11	89911111-89921767	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	18	"blood: 19.8"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 2.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	199	"basophil: 19.8"	"Lineage enriched"	"Detected in single"	199	"granulocytes: 19.8"																																					0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1			0.0		0.0	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682676	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	16	"blood: 73.8"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	679	"basophil: 73.8"	"Lineage enriched"	"Detected in single"	679	"granulocytes: 73.8"					"Low region specificity"	"Detected in many"			HPA072995	Approved				"Secreted to blood"					"HPA072995: AB_2732215"	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.4	1.2	0.3	1.1	0.3	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	1.1	0.3	0.7	0.8	0.8	0.3	0.3	0.1	0.5	0.3	4.6	1.1	0.3	0.3	0.3	0.3	3.7	1.4	0.3	0.3	0.4	0.0	0.3	0.4	0.3	0.3	1.6	1.0	0.3	0.3	0.7	0.2	1.0	0.3	1.3	0.8	0.3	0.3	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MS4A3	"CD20L, HTM4"	ENSG00000149516	"Membrane spanning 4-domains A3"	Q96HJ5	11	60056587-60071128	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 196.2;bone marrow: 105.4"	"Group enriched"	"Detected in some"	4	"HEL: 36.3;K-562: 30.9;NB-4: 25.1;THP-1: 73.3;U-937: 28.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebral cortex: 1.6"	"Cell type enriched"	"Detected in single"	1061	"basophil: 196.2"	"Lineage enriched"	"Detected in single"	1963	"granulocytes: 196.2"	"Not detected"	"Not detected"							HPA019210	Supported		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA019210: AB_1854134"					"unprognostic (6.37e-3)"			"unprognostic (1.25e-1)"						"unprognostic (2.67e-1)"	"unprognostic (3.77e-1)"			0.2	0.0	0.1	0.1	0.3	105.4	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	14.7	0.1	0.1	0.1	0.5	6.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.1	8.6	0.0	1.0	0.0	7.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	196.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	0.0	9.5	0.9	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	196.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.0
TRIM49D2	"TRIM49D2P, TRIM49L, TRIM49L1"	ENSG00000233802	"Tripartite motif containing 49D2"	C9J1S8	11	89924064-89933063	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"blood: 15.9"	"Cell line enriched"	"Detected in single"	6	"U-2 OS: 3.5"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	160	"basophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"																																					0.0	0.0		0.1		0.6	0.0		0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.3	0.2		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.6			0.0		0.0	0.1		0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HDC		ENSG00000140287	"Histidine decarboxylase"	P19113	15	50241947-50266026	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"blood: 83.5;brain: 36.0;epididymis: 36.9"	"Group enriched"	"Detected in some"	4	"HEL: 59.8;HMC-1: 143.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	52	"hypothalamus: 36.0"	"Cell type enriched"	"Detected in single"	835	"basophil: 83.5"	"Lineage enriched"	"Detected in single"	835	"granulocytes: 83.5"	"Region enriched"	"Detected in many"	5	"hypothalamus: 51.5"	"Low region specificity"	"Detected in all"			HPA038891	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA038891: AB_10673231"	"unprognostic (4.97e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.93e-7)"	"unprognostic (4.18e-5)"	"unprognostic (8.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.50e-1)"	1.7	0.2	0.2	5.1	0.4	2.4	1.1	0.2	0.3	2.7	1.9	0.2	1.2	2.1	3.1	36.9	2.7	0.6	6.6	2.1	0.2	36.0	0.6	0.8	4.9	2.3	0.6	0.1	0.4	0.5	0.3	0.7	0.2	0.3	2.2	1.9	3.0	0.9	1.3	1.8	1.8	2.4	5.4	0.2	0.4	6.9	2.4	0.2	0.4	0.3	0.4	1.7	1.8	2.7	0.0	0.0	83.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	59.8	0.0	0.0	0.0	0.1	143.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.2	0.3	0.2	36.0	0.6	0.1	0.3	0.2
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 15.8;blood: 32.3;brain: 28.3"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 41.1"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enriched"	"Detected in many"	5	"pons and medulla: 28.3"	"Cell type enriched"	"Detected in single"	127	"basophil: 32.3"	"Lineage enriched"	"Detected in single"	323	"granulocytes: 32.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 8.2"	"Low region specificity"	"Detected in all"			"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		140000	140000	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: , HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	1.0	15.8	0.5	0.8	6.0	0.9	0.4	0.0	0.7	0.9	1.1	0.1	0.0	0.8	1.6	2.0	0.7	0.6	2.1	1.5	0.0	1.2	2.9	0.2	1.9	0.3	2.1	0.6	0.3	0.3	0.3	1.1	0.5	28.3	2.2	0.2	3.1	1.2	0.5	0.7	0.2	0.4	1.1	1.2	0.2	1.0	2.4	1.5	0.4	0.3	0.0	0.4	0.7	0.8	0.0	0.0	32.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.6	0.0	6.6	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.0	2.1	0.7	0.0	0.0	0.0	1.1	0.0	0.6	1.2	0.0	0.1	0.0	0.0	0.7	9.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	32.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.0	0.0	0.6	0.0	1.2	2.1	0.6	28.3	1.5
AP002347.1		ENSG00000285231			11	59878809-59896481	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"blood: 7.4;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.4;HAP1: 1.4;K-562: 2.4;U-698: 3.0"									"Cell type enriched"	"Detected in single"	24	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 7.4"														"Secreted - unknown location"																							0.0	0.0		0.5		0.7	0.0		0.3	0.0	0.3			0.6	0.1	0.0	0.2	0.0	0.0	0.0			0.5	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.2		0.6	0.0	0.6	0.0	0.0	0.0		0.0	0.4	2.5			0.0		0.0	0.0		0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.9	1.4	0.0	0.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	2.4	0.3	0.4	0.7	0.0	0.3	0.8	0.0	0.0	0.0	0.5	0.4	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.3	3.0	0.0	0.2	0.2	7.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0										
OR6N1		ENSG00000197403	"Olfactory receptor family 6 subfamily N member 1"	Q8NGY5	1	158747814-158772195	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 7.5;bone marrow: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	18	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1			0.0		0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
RHEX	"C1orf186, FLJ16052"	ENSG00000263961	"Regulator of hemoglobinization and erythroid cell expansion"	Q6ZWK4	1	206052723-206102459	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"blood: 117.7"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 185.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 42.8;ovarian cancer: 41.1"					"Cell type enriched"	"Detected in some"	51	"basophil: 117.7"	"Lineage enriched"	"Detected in many"	51	"granulocytes: 117.7"					"Low region specificity"	"Detected in all"			HPA037859			Supported	"Plasma membrane"				"Plasma membrane"		"HPA037859: "	"unprognostic (9.26e-3)"	"unprognostic (1.91e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.27e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.04e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.80e-3)"	4.3	0.0	0.0	3.9	0.0	0.0	1.8	0.0	0.0	13.1	3.1	0.0	12.1	0.9	6.2	8.2	3.4	1.6	16.2	0.4	0.0		6.8	1.8	5.2	4.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	9.4	3.3	2.9	0.0	16.9	1.5	0.2	4.0	7.0	0.0	0.4	2.4	1.1	0.0	0.6	0.0	1.7	2.5	4.3	10.0	0.3	2.2	117.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.1	0.0	8.4	185.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	37.2	0.0	0.0	0.0	0.0	0.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	117.7	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2										
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet alpha subunit"	P07359	17	4932297-4935030	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.8"	"Cell line enriched"	"Detected in some"	24	"HEL: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	7	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported					2000000000	2000000000			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.7	0.1	0.4	15.8	1.2	5.3	0.7	1.9	0.7	0.7	1.0	0.2	0.2	1.5	0.6	0.7	5.7	0.8	0.3	4.2	0.5	0.4	1.0	1.6	3.5	37.8	0.4	0.2	0.7	0.4	0.0	0.4	1.1	0.4	0.7	0.6	0.3	7.7	0.2	3.0	4.6	3.7	0.2	0.4	13.0	0.9	0.6	0.2	2.0	0.8	0.8	17.6	0.9	1.1	0.0	0.3	7.5	0.2	0.0	0.2	3.6	0.0	1.3	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.1	1.2	0.4	0.0	1.3	0.0	0.0	0.0	0.4	1.0	39.3	0.5	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.3	0.2	0.1	0.2	0.6	0.3	0.2	0.0	0.7	0.0	0.2	0.5	0.0	0.2	1.6	0.7	0.1	0.2	0.2	0.8	0.1	0.7	0.2	0.9	0.6	0.6	0.4	7.5	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.3	0.0	3.6	0.4	1.2	1.9	0.4	0.5	0.4	0.4	0.2	0.4	0.2
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell line enriched"	"Detected in single"	166	"HEL: 37.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced					94000000	94000000			"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3
TRIM51	"SPRYD5, TRIM51A"	ENSG00000124900	"Tripartite motif-containing 51"	Q9BSJ1	11	55883297-55891810	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"blood: 11.0"	"Group enriched"	"Detected in some"	124	"SK-MEL-30: 35.2;WM-115: 9.0"	"Cancer enriched"	"Detected in single"	50	"melanoma: 4.3"					"Cell type enriched"	"Detected in single"	111	"basophil: 11.0"	"Lineage enriched"	"Detected in single"	111	"granulocytes: 11.0"									"HPA044988, HPA077883"	Uncertain		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA044988: AB_2679171, HPA077883: AB_2732362"									"unprognostic (9.60e-2)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3			0.0		0.0	0.1	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AP000790.4		ENSG00000285010			11	59964033-59970146	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"blood: 5.9;kidney: 1.5"	"Group enriched"	"Detected in some"	5	"HEL: 2.8;K-562: 7.1"									"Cell type enriched"	"Detected in single"	10	"basophil: 5.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.9"														"Secreted - unknown location"																							0.0	0.1		0.4		0.2	0.0		0.7	0.2	0.2			0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.5	0.0	0.0	0.0			0.5	0.0	0.0		0.0		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.1	0.0	0.8			0.0		0.0	0.0		0.5	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	2.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098466	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 72.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.9;NB-4: 2.6;THP-1: 4.1;U-937: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	720	"basophil: 72.0"	"Lineage enriched"	"Detected in single"	720	"granulocytes: 72.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059967	Enhanced									"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	4.9	0.5	0.4	5.1	0.4	0.2	2.1	0.4	0.4	11.9	4.6	0.1	4.5	4.7	14.3	11.2	5.9	1.1	14.6	2.1	0.4	0.4	1.5	0.9	12.9	0.5	0.4	0.1	1.1	1.2	0.2	0.6	0.6	0.1	17.5	5.6	4.5	3.2	5.4	1.5	4.3	7.4	15.9	0.4	0.6	4.5	2.7	0.2	1.2	0.6	6.7	3.4	5.1	4.1	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.3	0.0	6.9	0.4	0.2	0.3	0.8	0.4	0.1	0.1	0.0	0.1	0.1	0.9	0.3	0.0	0.1	0.0	2.6	0.1	0.1	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.1	0.2	0.0	0.3	4.1	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.2	1.8	0.2	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.2
OR52N2		ENSG00000180988	"Olfactory receptor family 52 subfamily N member 2"	Q8NGI0	11	5820314-5821348	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 7.0;testis: 2.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;SK-BR-3: 1.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	29	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 7.0"																											"unprognostic (3.45e-1)"		"unprognostic (2.81e-1)"	"unprognostic (3.44e-1)"				"unprognostic (7.82e-2)"			0.7	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.1			0.0	0.2	0.3	0.1	0.7	0.9	0.3	0.1	0.0	0.3	0.0	0.3	0.3	0.0		0.3	0.1	0.0	0.3	0.0		0.2	0.0		0.2	0.5	0.2	0.7	0.8	0.0	0.1	1.1	0.0	2.9			0.0		0.5	0.1	0.1	0.0	0.2	7.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0										
OR6K6		ENSG00000180433	"Olfactory receptor family 6 subfamily K member 6"	Q8NGW6	1	158754720-158755891	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"blood: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	57	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	57	"granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3			0.0		0.0	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C20orf203	FLJ33706	ENSG00000198547	"Chromosome 20 open reading frame 203"	Q8NBC4	20	32631652-32673941	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 4.2;ovary: 2.1"	"Cell line enhanced"	"Detected in some"		"HEL: 7.5;HMC-1: 5.2;NB-4: 2.2;U-266/70: 1.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	13	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 4.2"																				"unprognostic (6.24e-2)"	"unprognostic (3.39e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.25e-10)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-5)"	0.1	0.0		0.0		0.3	0.3		1.1	0.2	0.0			0.0	1.0	1.1	0.4	1.1	0.0	0.5			0.0	0.0	0.0	0.4			2.1	0.0	0.0		0.0		0.0	0.0		1.0	0.5	0.0	0.8	0.0	0.0		0.3	0.0	0.3			0.0		0.0	0.0		0.0	0.0	4.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.5	0.0	0.0	0.0	0.4	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	2.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0										
CCDC126	FLJ23031	ENSG00000169193	"Coiled-coil domain containing 126"	Q96EE4	7	23597379-23644708	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"basophil: 75.4"	"Lineage enriched"	"Detected in all"	18	"granulocytes: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026883	Uncertain		Approved	Nucleoplasm	"Secreted to blood"	31000000	31000000	Nucleoplasm		"HPA026883: AB_1846131"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-1)"	6.7	8.1	8.7	4.4	9.2	6.9	19.5	11.6	13.2	7.4	6.5	5.6	5.8	8.7	8.0	5.3	6.6	6.7	6.2	5.7	13.8	8.9	7.6	11.7	6.5	9.3	10.5	3.9	7.4	9.8	12.2	12.6	4.6	11.1	6.0	6.5	5.8	7.5	6.5	10.0	6.6	9.4	6.7	12.9	6.1	6.8	41.3	8.1	5.4	9.9	5.0	8.6	7.0	7.7	3.8	3.0	75.4	3.6	2.9	4.1	2.9	4.8	3.4	7.5	9.5	12.6	7.0	17.2	6.1	6.0	5.2	7.7	3.5	1.6	10.4	9.6	5.1	2.8	3.2	2.9	6.9	2.1	4.3	1.8	1.4	4.5	5.1	4.7	9.2	7.5	8.5	1.7	1.6	7.0	4.1	2.9	6.3	2.2	3.2	5.7	3.5	4.2	2.2	11.8	3.1	5.5	2.2	4.6	8.6	6.3	6.1	4.5	5.1	4.4	8.4	3.1	5.6	7.1	4.8	8.4	8.3	7.4	3.4	6.9	16.8	75.4	3.6	16.4	3.0	3.3	3.7	3.8	3.3	3.5	3.0	3.2	4.1	3.2	6.9	2.9	3.1	0.6	3.6	2.9	8.7	9.2	11.6	13.2	13.8	8.9	10.5	3.9	11.1	8.1
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 79.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	79.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4
EDARADD		ENSG00000186197	"EDAR associated death domain"	Q8WWZ3	1	236348257-236502915	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 24.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 36.7;RT4: 29.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	6	"basophil: 24.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 24.6"	"Group enriched"	"Detected in some"	5	"olfactory region: 0.7;thalamus: 0.8"	"Low region specificity"	"Detected in many"			HPA018836	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018836: AB_1847984"	"unprognostic (3.74e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.12e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.62e-3)"	0.9	0.4	0.5	2.4	0.5	0.2	5.8	0.3	0.4	1.1	1.1	0.1	13.7	0.2	0.9	13.0	7.2	1.0	1.3	2.2	0.4	0.4	2.5	0.6	1.7	1.2	0.5	0.0	0.7	5.5	0.0	0.4	6.4	0.1	11.3	0.2	1.7	3.6	16.6	0.3	5.7	0.7	3.6	0.4	2.9	6.4	4.0	0.2	4.5	6.4	5.3	6.8	15.6	9.9	0.1	0.3	24.6	0.2	2.9	4.0	1.1	0.0	1.7	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.4	0.4	0.0	0.0	0.0	0.1	4.1	3.0	4.4	0.7	5.9	3.5	0.0	0.0	0.6	0.0	0.1	36.7	0.0	1.3	0.5	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.8	0.0	1.5	0.0	0.0	0.0	29.7	0.2	0.1	0.0	0.6	0.1	7.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.6	0.2	0.0	2.1	0.2	2.7	0.1	3.2	4.0	0.3	0.1	0.3	2.1	0.2	2.9	0.1	0.0	2.9	1.1	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.0	0.1	0.2
GCSAML	"C1orf150, FLJ44728"	ENSG00000169224	"Germinal center associated signaling and motility like"	Q5JQS6	1	247507058-247577690	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 48.3;brain: 17.6"	"Group enriched"	"Detected in some"	73	"HEL: 27.8;HMC-1: 110.6"	"Cancer enriched"	"Detected in single"	13	"prostate cancer: 1.9"	"Region enriched"	"Detected in some"	10	"cerebellum: 17.6"	"Cell type enriched"	"Detected in single"	439	"basophil: 48.3"	"Lineage enriched"	"Detected in single"	439	"granulocytes: 48.3"					"Not detected"	"Not detected"			"HPA027507, HPA027510"	Uncertain		Approved	Cytosol				Cytosol		"HPA027507: AB_10600756, HPA027510: "	"unprognostic (5.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.76e-4)"	"unprognostic (3.21e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.51e-3)"	"unprognostic (3.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-2)"	3.7	0.3	0.4	1.1	0.4	2.4	1.6	17.6	0.4	3.8	2.1	0.2	0.0	2.2	2.4	2.2	1.9	0.6	2.7	1.3	0.4	0.5	0.5	0.4	5.6	1.1	0.5	0.0	0.3	0.5	0.1	0.4	0.3	1.7	9.5	2.4	0.4	1.0	0.9	0.5	1.2	2.5	6.6	0.9	0.5	1.4	5.3	0.0	1.4	0.4	2.4	1.5	3.4	9.4	0.1	0.0	48.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	110.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	48.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	17.6	0.4	0.4	0.5	0.5	0.0	1.7	0.0
IRGM	"IFI1, IRGM1, LRG-47, LRG47"	ENSG00000237693	"Immunity related GTPase M"	A1A4Y4	5	150846523-150900736	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 5.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.0;NB-4: 5.5;THP-1: 3.0;U-937: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.5"																				"unprognostic (8.73e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.62e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.12e-10)"	"unprognostic (5.93e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.11e-1)"	0.6	0.1	0.4	1.1	0.4	1.6	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.8	0.4	0.4	0.1	2.7	0.4	0.8	0.9	0.4	0.4	0.5	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.8	0.4	0.4	1.3	0.8	3.3	0.4	0.4	0.6	0.4	0.4	0.7	0.4	0.8	0.4	5.5	0.3	0.7	1.3	0.5	0.2	0.1	0.2	0.2	0.2	0.0	0.7	0.0	0.0	0.4	0.1	0.7	0.1	0.1	0.3	0.0	0.3	0.2	0.2	0.1	1.3	0.4	0.3	0.8	0.2	0.0	3.0	0.9	0.2	0.2	0.0	0.2	0.0	0.3	1.8	0.0	0.6	1.0	5.5	2.5	0.4	1.1	0.1	0.1	0.1	0.0	0.3	0.4	0.3	0.7	0.6	0.4	3.0	0.0	0.4	0.9	0.6	0.3	0.6	0.5	0.6	0.5	7.0	0.1	5.5	0.3	0.2	0.6	0.2	1.3	0.3	0.6	0.7	0.1	0.8	0.6	0.7	1.3	0.7	0.2	0.4	0.2	0.5	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
ISPD	"hCG_1745121, IspD, Nip"	ENSG00000214960	"Isoprenoid synthase domain containing"	A4D126	7	16087527-16421322	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 8.3;HEL: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.7"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043810, HPA053554"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA043810: AB_10964489, HPA053554: "	"unprognostic (4.65e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.39e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (1.38e-11)"	"unprognostic (4.01e-2)"	"unprognostic (1.78e-4)"	"unprognostic (6.26e-2)"	"unprognostic (2.79e-1)"	3.0	3.8	4.2	1.9	4.5	2.6	3.0	7.7	7.7	3.7	2.9	3.9	3.4	1.8	4.7	2.4	2.0	2.8	3.2	7.1	4.4	4.5	7.0	10.0	2.9	1.5	4.7	3.9	2.7	3.9	3.6	5.7	8.0	4.6	3.5	3.0	5.7	5.5	10.1	4.5	2.6	1.8	3.7	4.9	1.4	10.2	3.9	2.4	1.1	2.6	2.4	1.4	3.2	3.7	0.3	0.4	10.7	0.1	0.4	0.3	0.0	0.3	2.3	1.2	1.8	1.0	1.5	8.3	1.8	1.2	1.6	1.3	2.6	2.2	0.0	4.0	2.6	3.0	1.4	0.0	2.9	1.0	1.4	11.5	1.4	0.6	1.3	0.9	1.4	2.7	1.2	1.3	0.2	1.2	2.7	0.2	4.1	0.5	1.1	1.0	2.2	0.3	0.0	1.8	0.1	2.7	0.8	2.0	1.3	1.3	2.4	2.5	1.7	2.6	1.3	2.3	2.1	0.3	2.2	0.2	0.0	0.0	1.9	2.7	2.8	10.7	0.1	0.4	0.3	0.0	0.2	0.1	0.2	0.2	0.0	0.3	0.3	0.2	0.6	0.4	0.0	0.4	0.0	0.0	4.2	4.5	7.7	7.7	4.4	4.5	4.7	3.9	4.6	2.4
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Group enriched"	"Detected in some"	13	"HEL: 69.4;HMC-1: 118.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"		1100000000	1100000000	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10670151, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	69.4	0.0	0.6	0.0	0.0	118.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4
MS4A4E		ENSG00000214787	"Membrane spanning 4-domains A4E"	Q96PG1	11	60201253-60243088	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 17.1"	"Cell line enhanced"	"Detected in some"		"K-562: 5.1;NB-4: 1.7;THP-1: 7.3"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in some"	7	"basophil: 17.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 17.1"									HPA040075	Uncertain									"HPA040075: AB_10793915"	"unprognostic (1.90e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.16e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.97e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.05e-2)"	4.7	2.2	0.2	1.2	0.2	7.1	3.4	0.1	0.2	0.5	1.6			1.0	0.8	1.1	1.2	0.9	2.9	1.2	0.3	0.3	1.0	0.8	1.9	1.6	0.2		0.8	0.8	0.8	0.7	1.0		0.9	1.2		1.9	0.1	0.6	1.0	2.8	3.3	0.5	3.1	1.6	0.5			0.7		0.4	2.1	0.9	0.0	2.4	17.1	1.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	17.1	0.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	1.3	1.0	0.0	0.2										
MT-ND2	"MTND2, NAD2, ND2"	ENSG00000198763	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2"	P03891	MT	4470-5511	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 432.3"	"Cell line enhanced"	"Detected in all"		"HeLa: 601.0"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in all"	5	"basophil: 432.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 432.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.77e-1)"	"unprognostic (4.79e-2)"	"unprognostic (9.56e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.35e-2)"	93.0	57.2	116.0	16.9	169.9	15.6	33.9	40.1	73.5	22.6	53.7			50.1	21.5	59.8	29.0	22.1	19.3	262.4	112.2	85.2	125.9	128.9	20.9	14.7	113.0		25.1	62.0	24.3	20.3	37.0		28.1	59.0		85.3	41.0	263.4	72.7	39.2	24.6	72.4	15.2	49.2	27.3			18.2		17.7	23.8	13.1	66.1	43.5	432.3	54.8	43.0	57.9	21.8	92.8	102.3	91.6	154.4	330.8	59.0	86.6	86.7	21.7	23.2	29.3	128.7	125.5	133.3	82.5	62.2	166.7	14.4	108.4	50.2	116.0	74.5	153.8	601.0	207.5	67.8	149.2	179.0	97.6	198.2	57.0	56.5	34.0	112.1	130.7	55.7	109.8	84.6	241.4	45.9	67.0	74.4	51.3	111.8	171.8	143.7	57.3	68.7	37.5	115.2	138.2	177.3	172.5	107.5	87.2	108.0	122.6	109.8	85.5	73.2	112.2	56.6	128.8	39.0	432.3	54.8	93.1	34.1	39.7	54.7	58.6	39.5	42.5	23.0	66.1	48.5	57.9	88.6	43.0	45.7	43.5	25.9	21.8										
NCBP2L		ENSG00000170935	"Nuclear cap binding protein subunit 2 like"	A6PVI3	X	107774899-107795829	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 8.7;testis: 6.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.3;MCF7: 1.4;SK-BR-3: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	39	"basophil: 8.7"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 8.7"					"Low region specificity"	"Detected in single"			HPA010664	Uncertain									"HPA010664: AB_1079451"	"unprognostic (3.22e-1)"				"unprognostic (8.00e-2)"						"unprognostic (5.64e-2)"	"unprognostic (7.29e-2)"				"unprognostic (2.64e-1)"		0.0	3.1	0.3	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.0			0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.0	0.2		1.9	1.6	0.0	0.1	0.0		0.3	0.0		0.9	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	6.4			0.0		0.0	0.0	0.0	0.2	0.0	8.7	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4										
OR51I2		ENSG00000187918	"Olfactory receptor family 51 subfamily I member 2"	Q9H344	11	5449323-5456518	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"blood: 1.0"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	10	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"																																			0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.4	0.0			0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.3	0.7	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7			0.2		0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR6K3		ENSG00000203757	"Olfactory receptor family 6 subfamily K member 3"	Q8NGY3	1	158716327-158720720	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 10.4;bone marrow: 4.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055949	Uncertain									"HPA055949: AB_2682982"																		0.1	0.1	0.0	0.0	0.1	4.8	0.1	0.1	0.1	0.2	0.1			0.3	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	2.2	0.3	0.1		0.2	0.1	0.1	0.1	0.1		0.1	0.0		0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.1	0.4			0.1		0.0	0.2	0.1	1.3	1.0	10.4	0.9	0.9	1.5	0.3	0.2	0.3	0.1	0.9	0.6	0.2	0.5	0.2	0.4	0.4	0.2	0.6	0.7	1.1	0.3	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.5	0.2	0.8	0.3	0.8	0.6	0.3	1.8	0.3	0.5	2.7	0.1	0.6	0.3	1.0	0.1	0.0	0.4	0.2	0.4	0.2	0.6	0.4	0.0	0.0	0.3	0.1	0.2	0.0	1.6	0.6	0.5	0.4	0.1	0.6	0.6	0.6	0.0	0.6	0.7	10.4	0.9	0.9	1.3	0.8	1.4	1.1	1.3	1.0	0.4	1.3	1.4	1.5	1.7	0.9	0.7	1.0	0.9	0.3										
PLD3	HU-K4	ENSG00000105223	"Phospholipase D family member 3"	Q8IV08	19	40348456-40380439	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 149.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012800, CAB020812"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		490000	490000	"Endoplasmic reticulum, Cytosol"		"CAB020812: , HPA012800: AB_1855330"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.06e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.60e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (4.34e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.42e-2)"	45.7	57.5	44.6	23.1	79.0	12.8	21.9	35.5	126.1	31.2	23.5	25.4	17.1	22.6	26.3	35.0	18.3	30.0	30.8	33.0	46.4	73.4	22.1	25.6	49.7	25.2	44.7	53.9	44.8	42.5	32.9	122.1	38.9	62.2	29.6	16.1	31.6	35.3	37.2	27.4	24.2	23.5	25.6	28.6	48.9	23.0	17.0	19.3	11.9	20.6	11.2	12.9	27.3	20.7	3.6	23.0	149.2	24.6	9.7	7.8	16.8	13.9	43.2	28.0	44.0	77.9	37.1	21.3	34.7	35.4	25.2	28.9	8.2	15.8	6.1	36.4	30.1	6.5	6.7	13.6	11.0	22.6	24.6	6.5	14.8	10.3	53.2	2.7	75.0	70.6	28.5	19.2	13.2	21.1	23.0	24.6	18.1	18.3	4.7	13.0	18.2	8.9	6.0	21.3	24.9	12.9	10.5	20.1	33.4	16.6	10.3	18.5	14.2	47.0	37.2	21.3	10.2	18.0	7.7	25.6	27.3	6.3	34.2	10.9	13.1	149.2	24.6	35.3	7.8	12.8	6.4	3.6	6.2	6.9	23.0	3.1	6.5	6.5	2.5	9.7	5.7	3.3	6.1	16.8	44.6	79.0	35.5	126.1	46.4	73.4	44.7	53.9	62.2	19.3
PMM2	"CDG1, CDG1a, CDGS, PMI, PMI1"	ENSG00000140650	"Phosphomannomutase 2"	O15305	16	8788823-8849331	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 52.2"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 52.2"	"Low region specificity"	"Detected in all"							"HPA040852, HPA063649"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040852: AB_10794069, HPA063649: AB_2685074"	"unprognostic (8.62e-3)"	"unprognostic (8.00e-3)"	"prognostic favourable (1.04e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (5.14e-3)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (8.97e-6)"	"unprognostic (1.22e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.02e-2)"	14.8	13.1	6.8	15.4	9.0	4.3	13.6	8.2	8.2	11.4	19.4	7.0	11.6	18.9	9.7	13.1	22.7	10.0	13.9	10.7	4.7	2.9	14.6	43.3	11.8	11.2	6.6	4.3	7.8	40.4	7.8	28.3	19.9	6.6	12.0	20.4	8.8	21.2	13.5	12.5	13.2	19.6	9.5	5.7	12.0	15.2	9.7	7.8	7.6	10.0	12.0	22.0	10.5	12.2	2.9	3.5	52.2	4.9	1.6	3.6	3.0	10.9	24.5	5.4	14.2	9.7	15.3	12.1	17.1	20.7	17.2	18.6	18.3	13.6	17.5	7.2	29.8	15.2	11.1	20.9	17.6	13.0	13.0	5.8	14.8	31.2	18.4	15.3	13.9	22.8	14.9	18.3	16.9	17.5	7.8	17.1	11.4	28.7	15.6	14.1	23.0	15.9	19.9	12.1	34.8	19.1	19.4	10.3	19.5	14.1	31.1	10.2	20.2	13.4	20.3	12.4	14.0	33.4	16.7	21.2	17.7	22.0	10.3	19.3	16.4	52.2	4.9	0.9	2.5	3.7	3.6	2.9	2.2	3.2	3.5	2.4	2.5	2.4	7.8	1.6	2.3	3.2	1.6	3.0	6.8	9.0	8.2	8.2	4.7	2.9	6.6	4.3	6.6	7.8
RGS13		ENSG00000127074	"Regulator of G protein signaling 13"	O14921	1	192636138-192660306	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 46.9"	"Cell line enriched"	"Detected in some"	17	"Daudi: 33.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	35	"basophil: 9.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 9.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA044952	Uncertain									"HPA044952: AB_10964914"	"unprognostic (1.99e-2)"	"unprognostic (6.08e-3)"	"unprognostic (3.25e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.96e-1)"	2.2	0.1	0.1	46.9	0.6	0.2	1.3	0.1	0.1	2.4	4.2	0.0	1.1	2.2	1.5	1.3	1.3	0.4	3.5	0.4	0.1	0.4	0.5	0.2	3.6	31.7	0.2	0.0	0.2	0.7	0.0	0.8	0.0	0.1	3.9	1.0	0.5	1.4	1.6	0.3	1.9	11.9	2.9	0.2	1.2	1.9	0.7	0.0	0.6	0.6	1.7	22.9	1.4	1.8	0.2	0.1	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0
SCCPDH	"CGI-49, NET11"	ENSG00000143653	"Saccharopine dehydrogenase (putative)"	Q8NBX0	1	246724047-246768137	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 95.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	17	"basophil: 95.3"	"Lineage enriched"	"Detected in all"	22	"granulocytes: 95.3"	"Low region specificity"	"Detected in all"							"HPA050775, HPA076030"	Enhanced		Approved	Vesicles		2100000	2100000	Vesicles		"HPA050775: AB_2681231, HPA076030: "	"unprognostic (4.25e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-2)"	14.1	25.8	15.7	6.4	17.5	13.4	11.3	11.3	20.5	10.9	11.7	24.7	8.5	15.1	12.0	8.5	4.8	14.4	9.7	15.8	15.6	19.8	23.0	67.3	9.3	7.3	26.1	15.0	10.6	12.7	15.0	12.7	14.1	21.7	18.1	12.2	7.3	7.4	16.7	23.9	10.7	15.3	10.8	62.1	5.1	12.4	65.1	17.5	8.5	18.2	7.3	4.8	25.0	13.2	1.4	2.3	95.3	3.2	4.2	3.0	2.1	12.8	12.6	9.2	5.5	11.0	14.0	0.1	10.1	14.1	17.1	14.3	7.7	36.3	6.8	13.3	11.6	4.2	7.8	3.0	17.6	9.5	2.8	11.6	11.5	15.3	10.4	22.5	10.0	9.3	1.4	11.5	1.2	18.3	14.4	0.0	17.0	3.1	23.4	28.6	13.8	10.0	19.7	11.8	0.0	52.5	30.4	10.5	11.8	13.7	0.6	8.9	10.2	23.5	11.9	7.9	7.1	19.2	26.0	34.1	11.7	4.1	13.5	30.7	10.4	95.3	3.2	5.5	2.5	2.8	3.0	1.4	0.7	2.1	1.3	1.1	1.0	3.0	0.8	4.2	1.8	2.3	0.5	2.1	15.7	17.5	11.3	20.5	15.6	19.8	26.1	15.0	21.7	17.5
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favourable (4.53e-4)"	"prognostic unfavourable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.6	10.6	2.8	14.5	10.0	10.9	18.8	18.4	11.2	12.4	12.6	9.4	12.0	18.8	35.0	17.6	21.3	9.3	9.4	3.3	12.2	4.4	5.8	14.0	7.4	18.4	6.9	9.5	13.6	10.7	11.6	6.3	8.5	6.5	18.5	8.1	32.8	3.7	6.2	2.2	20.5	6.1	7.6	14.2	9.4	9.2	2.6	4.7	11.6	21.0	4.8	6.8	5.5	11.1	14.9	9.3	34.4	23.2	13.2	12.7	19.4	15.8	14.5	7.6	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.4;U-138 MG: 12.5;U-2 OS: 13.6;U-266/70: 19.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"basophil: 55.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 55.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"				"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favourable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	8.3	1.5	2.3	9.0	3.7	9.4	3.8	0.8	2.4	5.1	7.4	7.1	0.6	2.9	4.6	5.5	3.6	11.6	7.3	5.3	3.4	2.0	4.7	2.2	20.2	26.7	3.5	1.3	2.5	2.3	0.9	2.1	1.3	5.5	5.3	1.8	4.8	12.4	4.8	11.4	3.0	12.0	3.5	10.4	21.9	5.8	3.2	3.9	2.3	21.7	1.2	24.5	18.8	3.6	0.2	1.3	55.6	4.5	10.9	10.2	4.4	4.8	0.7	0.0	0.3	0.7	0.7	0.2	1.9	1.3	0.5	1.4	0.4	3.9	0.0	0.4	3.4	0.5	0.1	0.6	1.9	9.5	0.2	3.7	0.1	0.0	1.2	1.0	16.4	2.2	1.4	4.1	0.7	0.9	0.2	3.7	4.9	0.2	0.1	1.3	0.1	0.7	0.0	4.0	0.4	1.9	0.2	10.9	0.8	0.7	6.9	0.5	1.3	0.2	5.7	12.5	13.6	0.3	0.4	19.2	4.3	0.4	8.1	5.3	0.4	55.6	4.5	0.2	10.2	0.8	6.0	0.2	4.1	6.8	1.3	0.0	4.5	5.5	9.2	10.9	0.3	0.3	4.1	4.4	2.3	3.7	0.8	2.4	3.4	2.0	3.5	1.3	5.5	3.9
TRIM64C		ENSG00000214891	"Tripartite motif containing 64C"		11	49053714-49059112	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"blood: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	16	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"									HPA045370	Uncertain									"HPA045370: AB_2679298"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.3		0.0	0.3		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
Z84488.2		ENSG00000285446			6	116399395-116463696	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.5;lymphoid tissue: 3.0"	"Cell line enhanced"	"Detected in some"		"BJ: 3.4;HDLM-2: 3.7;hTEC/SVTERT24-B: 2.8;Karpas-707: 4.3;RPMI-8226: 3.2;SiHa: 2.4"									"Cell type enriched"	"Detected in single"	6	"basophil: 3.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.5"																																					0.5	0.0		0.0		0.4	0.0		0.1	0.1	0.0			0.0	0.0	0.0	0.2	0.8	1.5	0.0			0.0	0.4	0.2	0.1			0.2	0.0	0.0		0.1		0.0	0.1		0.7	0.0	0.0	0.0	0.4	0.0		3.0	1.1	0.0			0.0		0.5	0.0		0.5	0.1	3.5	0.3	0.0	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	1.2	0.0	0.0	0.0	0.8	0.0	1.4	0.2	1.8	0.9	3.7	0.0	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.3	2.8	0.0	0.8	0.0	4.3	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	3.2	0.0	0.6	0.0	0.0	2.4	0.2	0.7	0.0	0.0	0.0	0.2	0.1	0.0	1.9	0.5	0.0	0.1	0.2	0.8	0.0	3.5	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.2	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
